Faculty of Pharmaceutical Sciences

Activities

Activities per year 1990 2011 2012 2013 2014 2015 2016 2017 2018 2025

• 2140 Oral presentation
• 78 social activities
• 52 Academic activities
• 18 Invited talk
• 12 More
  • 5 Other reseach activity
  • 5 Other educational activity
  • 1 Participating in a conference, workshop
  • 1 Editorial work

Activities per year

Search results

• 高大連携

  Tomohiro, T. (Participant)

  2011/08

  Activity: Other › social activities

• Deltamethrin, a type II pyrethroid insecticide, induces neurotrophic effects on neurons with a continuous activation of #IBdnf#IR promoter IV.

  Ihara, D. (Speaker)

  2011/08

  Activity: Talk or presentation › Oral presentation

• Differential expression of rat SRF coactivator MKL1 transcripts during brain development: the possible involvement in dendritic morphology.

  Tabuchi, A. (Speaker)

  2011/08

  Activity: Talk or presentation › Oral presentation

• 電気化学応答ＤＮＡプローブによるAPOBEC3G酵素反応の検出

  Chiba, J. (Speaker)

  2011/07/22 → 2011/07/23

  Activity: Talk or presentation › Oral presentation

• 薬学教育におけるSP養成およびPBLチュートリアル教育の現状

  Nitta, A. (Speaker)

  2011/07/22 → 2011/07/23

  Activity: Talk or presentation › Oral presentation

• 光クロスリンクを利用した相互作用部位への新規蛍光タグ化

  Tomohiro, T. (Speaker)

  2011/07/22 → 2011/07/23

  Activity: Talk or presentation › Oral presentation

• N-アセチルノイラミン酸のアニオン部位近傍に光反応基を有する光プローブの開発

  Tomohiro, T. (Speaker)

  2011/07/11 → 2011/07/13

  Activity: Talk or presentation › Oral presentation

• Synthesis and Anticancer Activity of Antimycin A3 Analogue

  Tanimoto, H. (Speaker)

  2011/07

  Activity: Talk or presentation › Oral presentation

• 細菌性髄膜炎症例におけるリネゾリドの髄液および血中動態の検討

  To, H. (Speaker)

  2011/07

  Activity: Talk or presentation › Oral presentation

• 関節リウマチ治療におけるメトトレキサートの時間薬物療法

  To, H. (Speaker)

  2011/07

  Activity: Talk or presentation › Oral presentation

• リピッドホスファターゼSHIP2阻害による新規インスリン抵抗性改善薬の開発

  Tsuneki, H. (Speaker)

  2011/06/29 → 2011/07/01

  Activity: Talk or presentation › Oral presentation

• リピッドホスファターゼSHIP2阻害による新規インスリン抵抗性改善薬の開発

  Sasaoka, T. (Speaker)

  2011/06/29 → 2011/07/01

  Activity: Talk or presentation › Oral presentation

• Blockade of mineralocorticoid receptor improves insulin resistance and steatohepatitis in a novel mouse model of non-alchoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

  Wada, T. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Blockade of mineralocorticoid receptor improves insulin resistance and steatohepatitis in a novel mouse model of non-alchoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

  Tsuneki, H. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Blockade of mineralocorticoid receptor improves insulin resistance and steatohepatitis in a novel mouse model of non-alchoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

  Sasaoka, T. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Brain signaling of long-acting insulin analogues glargine and detemir for the regulation of glucose metabolism and learning/memory in mice.

  Tsuneki, H. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Role of hypothalamic orexin in the regulation of hepatic insulin sensitivity in mice.

  Wada, T. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Overexpression of SHIP2 causes insulin but not leptin resistance in the hypothalamus and dysregulation of energy homeostasis in mice.

  Wada, T. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Role of hypothalamic orexin in the regulation of hepatic insulin sensitivity in mice.

  Sasaoka, T. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Role of hypothalamic orexin in the regulation of hepatic insulin sensitivity in mice.

  Tsuneki, H. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Brain signaling of long-acting insulin analogues glargine and detemir for the regulation of glucose metabolism and learning/memory in mice.

  Wada, T. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Overexpression of SHIP2 causes insulin but not leptin resistance in the hypothalamus and dysregulation of energy homeostasis in mice.

  Sasaoka, T. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Overexpression of SHIP2 causes insulin but not leptin resistance in the hypothalamus and dysregulation of energy homeostasis in mice.

  Tsuneki, H. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Brain signaling of long-acting insulin analogues glargine and detemir for the regulation of glucose metabolism and learning/memory in mice.

  Sasaoka, T. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• 特異的SREBP1c過剰発現と脂肪・果糖負荷による脂肪性肝炎：アルドステロン阻害薬の効果と創薬

  Sasaoka, T. (Speaker)

  2011/06/17 → 2011/06/18

  Activity: Talk or presentation › Oral presentation

• 精神病関連遺伝子Shatiの脳部位特異的過剰発現マウスにおける行動解析

  Nitta, A. (Speaker)

  2011/06/17 → 2011/06/18

  Activity: Talk or presentation › Oral presentation

• リピッドホスファターゼSHIP2が中枢性エネルギー代謝に与える影響

  Sasaoka, T. (Speaker)

  2011/06/17 → 2011/06/18

  Activity: Talk or presentation › Oral presentation

• “ジストニア” モデル動物における新規遺伝子Shatiの役割

  Nitta, A. (Speaker)

  2011/06/17 → 2011/06/18

  Activity: Talk or presentation › Oral presentation

• リピッドホスファターゼSHIP2が中枢性エネルギー代謝に与える影響

  Wada, T. (Speaker)

  2011/06/17 → 2011/06/18

  Activity: Talk or presentation › Oral presentation

• 特異的SREBP1c過剰発現と脂肪・果糖負荷による脂肪性肝炎：アルドステロン阻害薬の効果と創薬

  Wada, T. (Speaker)

  2011/06/17 → 2011/06/18

  Activity: Talk or presentation › Oral presentation

• 特異的SREBP1c過剰発現と脂肪・果糖負荷による脂肪性肝炎：アルドステロン阻害薬の効果と創薬

  Tsuneki, H. (Speaker)

  2011/06/17 → 2011/06/18

  Activity: Talk or presentation › Oral presentation

• リピッドホスファターゼSHIP2が中枢性エネルギー代謝に与える影響

  Tsuneki, H. (Speaker)

  2011/06/17 → 2011/06/18

  Activity: Talk or presentation › Oral presentation

• Synthesis of multifunctional diazirine probes and their application in the chemical biology

  Tomohiro, T. (Speaker)

  2011/06/07 → 2011/06/08

  Activity: Talk or presentation › Oral presentation

• 関節リウマチ発症による炎症性サイトカインの概日リズム形成機構の解析

  To, H. (Speaker)

  2011/06

  Activity: Talk or presentation › Oral presentation

• 薬物乱用防止教室講義教室講師

  Nitta, A. (Participant)

  2011/06

  Activity: Other › social activities

• 日本医療薬学会 (External organization)

  To, H. (Member)

  2011/06 → …

  Activity: Membership › Academic activities

• TRPA1発現線維が入力する脊髄膠様質細胞の形態学的特徴

  Uta, D. (Speaker)

  2011/05/29 → 2011/05/30

  Activity: Talk or presentation › Oral presentation

• フェロセン連結ＤＮＡプローブによるAPOBEC3G酵素反応の電気化学的評価

  Chiba, J. (Speaker)

  2011/05/23 → 2011/05/25

  Activity: Talk or presentation › Oral presentation

• 三種類の人工核酸塩基を導入したアルキニル C-ヌクレオシドの合成とそのオリゴマー化

  Chiba, J. (Speaker)

  2011/05/23 → 2011/05/25

  Activity: Talk or presentation › Oral presentation

• アルキニル C-ヌクレオシドをモノマーユニットとする人工ＤＮＡと天然ＤＮＡから成るヘテロ２重鎖の熱力学的評価

  Chiba, J. (Speaker)

  2011/05/23 → 2011/05/25

  Activity: Talk or presentation › Oral presentation

• 光化学的蛍光ラベル化を目的とした発蛍光性ATPプローブの開発

  Tomohiro, T. (Speaker)

  2011/05/23 → 2011/05/25

  Activity: Talk or presentation › Oral presentation

• 視床下部ペプチドのオレキシンによるマウス肝糖新生の調節作用に対する自律神経遮断薬の効果の解析

  Sasaoka, T. (Speaker)

  2011/05/19 → 2011/05/21

  Activity: Talk or presentation › Oral presentation

• エストロゲンの中枢及び末梢投与が全身のエネルギーバランス、体脂肪分布と糖・脂質代謝に与える影響

  Wada, T. (Speaker)

  2011/05/19 → 2011/05/21

  Activity: Talk or presentation › Oral presentation

• アンジオテンシンⅡによる培養血管内皮細胞の酸化ストレス障害に対するコエンザイムQ10の改善効果

  Tsuneki, H. (Speaker)

  2011/05/19 → 2011/05/21

  Activity: Talk or presentation › Oral presentation

• 長期的な視床下部オレキシンの欠損がマウス肝臓の糖新生機能を障害するメカニズムの解析

  Sasaoka, T. (Speaker)

  2011/05/19 → 2011/05/21

  Activity: Talk or presentation › Oral presentation

• 2型糖尿病モデルマウスの認知機能障害に対するリピッドホスファターゼSHIP2阻害剤の改善効果の解析

  Sasaoka, T. (Speaker)

  2011/05/19 → 2011/05/21

  Activity: Talk or presentation › Oral presentation

• 2型糖尿病モデルマウスの認知機能障害に対するリピッドホスファターゼSHIP2阻害剤の改善効果の解析

  Tsuneki, H. (Speaker)

  2011/05/19 → 2011/05/21

  Activity: Talk or presentation › Oral presentation

• 3T3L1脂肪細胞においてインターフェロンβはStat1を、インターフェロンγはStat3を介してインスリン抵抗性を誘導する

  Sasaoka, T. (Speaker)

  2011/05/19 → 2011/05/21

  Activity: Talk or presentation › Oral presentation

• マウスでの持効型インスリンアナログの中枢作用の特徴

  Tsuneki, H. (Speaker)

  2011/05/19 → 2011/05/21

  Activity: Talk or presentation › Oral presentation

• 3T3L1脂肪細胞においてインターフェロンβはStat1を、インターフェロンγはStat3を介してインスリン抵抗性を誘導する

  Wada, T. (Speaker)

  2011/05/19 → 2011/05/21

  Activity: Talk or presentation › Oral presentation